Literature DB >> 7134238

Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.

B Johnels.   

Abstract

A mechanographic method was used to assess the locomotor performance induced by apomorphine or other dopaminergic drugs in reserpine-treated rats. Reserpine was found to induce locomotor hypokinesia. The hypokinesia was dose-dependently reversed by apomorphine (APO), bromocriptine and pergolide. Locomotion was induced by microinjection of APO into the nucleus accumbens. No locomotor effect was found after injection into corpus striatum. Injection into both nuclei was not superior to accumbens only. Intra-striatal or intraaccumbens injections of trifluoperazine blocked the effect on locomotion by systematic apomorphine. The results confirmed that reserpine-induced locomotor hypokinesia is reversed by dopaminergic stimulation in the nucleus accumbens. There were indications that blockade of striatal or accumbens' dopamine receptors counteracts apomorphine-induced locomotion presumably by interaction with postural motor control. Evidence was found for separate dopaminergic control of locomotion and muscletone. This may be of importance for the development of new antiparkinson drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7134238     DOI: 10.1016/0091-3057(82)90082-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

1.  Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice.

Authors:  A Svensson; M L Carlsson; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 2.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

3.  Interactions between central glutamatergic, catecholaminergic and cholinergic systems with regard to locomotor activity in monoamine-depleted mice.

Authors:  A Svensson; M L Carlsson; A Carlsson
Journal:  Amino Acids       Date:  1992-06       Impact factor: 3.520

Review 4.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

5.  Actigraphic measurement of the effects of single-dose haloperidol and olanzapine on spontaneous motor activity in normal subjects.

Authors:  Michael Kiang; Z Jeff Daskalakis; Bruce K Christensen; Gary Remington; Shitij Kapur
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

6.  Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion.

Authors:  P Brundin; R E Strecker; E Londos; A Björklund
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

Review 7.  Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

Authors:  Susan Duty; Peter Jenner
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

8.  Attenuation of reserpine-induced fibromyalgia via ROS and serotonergic pathway modulation by fisetin, a plant flavonoid polyphenol.

Authors:  Xianli Yao; Li Li; Amit D Kandhare; Anwesha A Mukherjee-Kandhare; Subhash L Bodhankar
Journal:  Exp Ther Med       Date:  2019-12-13       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.